% Expired Patents = 20.0

EPO Patents = 1

Forward Citations = 6

Loading Chart...

8 inventors (with patents filed for the assignee):

Aprile L Pilon (4 out of 13 patents)

Melissa E Winn (2 out of 9 patents)

Humcha K Hariprakasha (1 out of 4 patents)

4. Richard S Clayton (1 out of 4 patents)

5. John K Zehmer (1 out of 3 patents)

6. Aprile L Pilon-Clayton (1 out of 1 patent)

7. Louis Flamand (1 out of 1 patent)

8. Pierre Borgeat (1 out of 7 patents)

5 patents: Sort by Forward Citations

1. 9844580 - Recombinant human CC10 and compositions thereof for use in the treatment of nasal rhinitis (2017-12-19),

2. 9765127 - Compositions and methods of use for recombinant human secretoglobins (2017-09-19),

3. 9394349 - Modification and compositions of human secretoglobin proteins (2016-07-19),

4. 9168285 - Recombinant human CC10 protein for treatment of influenza and ebola (2015-10-27),

5. 8957018 - Recombinant human CC10 protein for treatment of influenza (2015-02-17),

Company Overview

Therabron Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapeutics for respiratory diseases. Their innovative approach includes a pipeline of drug candidates targeting important unmet needs in the treatment of respiratory conditions. Therabron Therapeutics is committed to improving the lives of patients with respiratory diseases through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#106 in Rockville, MD

#750 in Maryland

#51,620 in US

Rockville, MD, United States of America

Therabron Therapeutics, Inc.

Forward Citations = 6

8 inventors:

Aprile L Pilon (4 out of 13 patents)

Melissa E Winn (2 out of 9 patents)

Humcha K Hariprakasha (1 out of 4 patents)

4. Richard S Clayton (1 out of 4 patents)

5. John K Zehmer (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Therabron Therapeutics, Inc.. Retrieved from https://idiyas.com/company/therabron-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]